Loading...
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
Treatment options for neuroendocrine tumors (NETs) and carcinomas (NECs) are expanding. Early-phase studies have shown preliminary evidence of the antitumor activity of alpha-emitting peptide receptor radionuclide therapy (PRRT), and novel radiopeptides incorporating somatostatin receptor antagonist...
Na minha lista:
| Udgivet i: | J Clin Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7696369/ https://ncbi.nlm.nih.gov/pubmed/33202931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113655 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|